These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2667326)

  • 1. Interferon alternating with chemotherapy for patients with metastatic renal cell carcinoma.
    Dexeus FH; Logothetis CJ; Sella A; Finn L
    Am J Clin Oncol; 1989 Aug; 12(4):350-4. PubMed ID: 2667326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.
    Kim NK; Park YS; Heo DS; Suh C; Kim SY; Park KC; Kang YK; Shin DB; Kim HT; Kim HJ
    Cancer; 1993 Jun; 71(12):3813-8. PubMed ID: 8508349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is cytotoxic chemotherapy effective in the treatment of advanced renal cell carcinoma?
    Swanson DA
    Semin Urol; 1993 Feb; 11(1):35-40. PubMed ID: 7682003
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II study of interferon-alpha and chemotherapy (5-fluorouracil and mitomycin C) in metastatic renal cell cancer.
    Sella A; Logothetis CJ; Fitz K; Dexeus FH; Amato R; Kilbourn R; Wallace S
    J Urol; 1992 Mar; 147(3):573-7. PubMed ID: 1538431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution patients.
    Lopez Hänninen E; Kirchner H; Atzpodien J
    J Urol; 1996 Jan; 155(1):19-25. PubMed ID: 7490829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon therapy for metastatic renal cell carcinoma.
    Swanson DA; Quesada JR
    Semin Surg Oncol; 1988; 4(3):174-7. PubMed ID: 3142007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
    Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL
    Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose mitomycin and weekly low-dose doxorubicin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, and 5-fluorouracil.
    Colozza M; Tonato M; Grignani F; Davis S
    Cancer; 1988 Jul; 62(2):262-5. PubMed ID: 3383126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternating chemotherapy in advanced gastric cancer. A phase II study.
    Feliu J; Girón CG; González-Baron M; Berrocal A; Barón-Saura JM
    Cancer Chemother Pharmacol; 1991; 28(4):313-4. PubMed ID: 1908751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide versus 5-fluorouracil, doxorubicin, and mitomycin C (FAM') in the treatment of hormone-resistant metastatic carcinoma of the prostate: a preliminary report of a randomized trial.
    Kasimis BS; Miller JB; Kaneshiro CA; Forbes KA; Moran EM; Metter GE
    J Clin Oncol; 1985 Mar; 3(3):385-92. PubMed ID: 3838343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma.
    Lele SB; Piver MS
    Gynecol Oncol; 1989 Apr; 33(1):6-8. PubMed ID: 2467845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European studies of interleukin-2 in metastatic renal cell carcinoma.
    Atzpodien J; Kirchner H; Hänninen EL; Körfer A; Fenner M; Menzel T; Deckert M; Franzke A; Jonas U; Poliwoda H
    Semin Oncol; 1993 Dec; 20(6 Suppl 9):22-6. PubMed ID: 8284688
    [No Abstract]   [Full Text] [Related]  

  • 13. 5-Fluorouracil versus a combination of BCNU, adriamycin, 5-FU and mitomycin C in advanced gastric cancer: a prospective randomized study of the Italian Clinical Research Oncology Group.
    De Lisi V; Cocconi G; Tonato M; Di Costanzo F; Leonardi F; Soldani M
    Recent Results Cancer Res; 1988; 110():212-8. PubMed ID: 3136519
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of value for cisplatin added to mitomycin-doxorubicin combination chemotherapy for carcinoma of unknown primary site. A randomized trial.
    Eagan RT; Therneau TM; Rubin J; Long HJ; Schutt AJ
    Am J Clin Oncol; 1987 Feb; 10(1):82-5. PubMed ID: 3548315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
    De Lisi V; Cocconi G; Angelini F; Cavicchi F; Di Costanzo F; Gilli G; Rodinò C; Soldani M; Tonato M; Finardi C
    Cancer; 1996 Jan; 77(2):245-50. PubMed ID: 8625230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of carcinoma of renal pelvis: preliminary report.
    Trindade A; Samuels ML; Logothetis CJ
    Urology; 1981 Jul; 18(1):54-9. PubMed ID: 6894814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive interferon-alpha-2c in stage IIIB/IV small-cell lung cancer: a phase III trial.
    Prior C; Oroszy S; Oberaigner W; Schenk E; Kummer F; Aigner K; Hausmaninger H; Peschel C; Huber H
    Eur Respir J; 1997 Feb; 10(2):392-6. PubMed ID: 9042638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma.
    Sznol M; Clark JW; Smith JW; Steis RG; Urba WJ; Rubinstein LV; VanderMolen LA; Janik J; Sharfman WH; Fenton RG
    J Natl Cancer Inst; 1992 Jun; 84(12):929-37. PubMed ID: 1629914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic options in renal-cell carcinoma.
    Krown SE
    Semin Oncol; 1985 Dec; 12(4 Suppl 5):13-7. PubMed ID: 2417331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.
    Chahinian AP; Propert KJ; Ware JH; Zimmer B; Perry MC; Hirsh V; Skarin A; Kopel S; Holland JF; Comis RL
    J Clin Oncol; 1989 Aug; 7(8):993-1002. PubMed ID: 2547030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.